CID 121364961

Zabedosertib

Structural Information

Molecular Formula
C20H21F3N4O4S
SMILES
CC(C)(C1=CC2=NN(C=C2C=C1NC(=O)C3=NC(=CC=C3)C(F)(F)F)CCS(=O)(=O)C)O
InChI
InChI=1S/C20H21F3N4O4S/c1-19(2,29)13-10-15-12(11-27(26-15)7-8-32(3,30)31)9-16(13)25-18(28)14-5-4-6-17(24-14)20(21,22)23/h4-6,9-11,29H,7-8H2,1-3H3,(H,25,28)
InChIKey
OQAMEEFUUFJZRS-UHFFFAOYSA-N
Compound name
N-[6-(2-hydroxypropan-2-yl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

5
References

198
Patents

470.12357 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 471.13085 209.0
[M+Na]+ 493.11279 218.1
[M-H]- 469.11629 208.9
[M+NH4]+ 488.15739 215.7
[M+K]+ 509.08673 212.2
[M+H-H2O]+ 453.12083 198.9
[M+HCOO]- 515.12177 216.2
[M+CH3COO]- 529.13742 231.0
[M+Na-2H]- 491.09824 211.9
[M]+ 470.12302 211.8
[M]- 470.12412 211.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe